- Home
- LUNR vs COLL Comparison
LUNR vs COLL Comparison
Compare LUNR & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNR
- COLL
- Stock Information
- Founded
- LUNR 2013
- COLL 2002
- Country
- LUNR United States
- COLL United States
- Employees
- LUNR N/A
- COLL N/A
- Industry
- LUNR Industrial Machinery/Components
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- LUNR Industrials
- COLL Health Care
- Exchange
- LUNR Nasdaq
- COLL Nasdaq
- Market Cap
- LUNR 812.2M
- COLL 910.2M
- IPO Year
- LUNR N/A
- COLL 2015
- Fundamental
- Price
- LUNR $7.45
- COLL $27.01
- Analyst Decision
- LUNR Strong Buy
- COLL Strong Buy
- Analyst Count
- LUNR 6
- COLL 5
- Target Price
- LUNR $15.00
- COLL $43.60
- AVG Volume (30 Days)
- LUNR 10.0M
- COLL 500.0K
- Earning Date
- LUNR 05-13-2025
- COLL 05-08-2025
- Dividend Yield
- LUNR N/A
- COLL N/A
- EPS Growth
- LUNR N/A
- COLL 43.56
- EPS
- LUNR N/A
- COLL 1.86
- Revenue
- LUNR $228,000,000.00
- COLL $631,449,000.00
- Revenue This Year
- LUNR $21.92
- COLL $19.96
- Revenue Next Year
- LUNR $42.00
- COLL $3.93
- P/E Ratio
- LUNR N/A
- COLL $14.55
- Revenue Growth
- LUNR 186.61
- COLL 11.41
- 52 Week Low
- LUNR $3.15
- COLL $23.23
- 52 Week High
- LUNR $24.95
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- LUNR 40.45
- COLL 43.16
- Support Level
- LUNR $7.41
- COLL $23.23
- Resistance Level
- LUNR $8.19
- COLL $27.57
- Average True Range (ATR)
- LUNR 0.79
- COLL 1.45
- MACD
- LUNR 0.29
- COLL -0.08
- Stochastic Oscillator
- LUNR 53.56
- COLL 51.82
About LUNR Intuitive Machines Inc.
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.